Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 26, 2015 8:49 AM ET

Company Overview of Innovative Medicines Initiative

Company Overview



Key Executives for Innovative Medicines Initiative

Innovative Medicines Initiative does not have any Key Executives recorded.

Innovative Medicines Initiative Key Developments

Innovative Medicines Initiative Manes Pierre Meulien as its New Executive Director

Innovative Medicines Initiative (IMI) named Pierre Meulien as its new Executive Director. Pierre Meulien comes to IMI from Genome Canada and will take up his duties at IMI in mid-September 2015. He brings with him a wealth of experience working in academia, the pharmaceutical industry, and research-funding organizations on both sides of the Atlantic. The news was announced at IMI's annual Stakeholder Forum in Brussels, Belgium. Pierre Meulien is currently President and Chief Executive Officer (CEO) of Genome Canada, While at Genome Canada, he succeeded in securing significant funding from the Government of Canada and leveraged further funds through partnerships.

Similar Private Companies By Industry

Company Name Region
Pagaddertoren NV Europe
Sogephar SPRL Europe
Pineapple Design SA Europe
Avifor CVA Europe
Entreprises Generales De Construction Wastiau Jean SA Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Innovative Medicines Initiative, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at